Novartis AG ADR buy skatcup
Start price
21.09.20
/
70%
€75.50
Target price
04.11.21
€90.00
Performance (%)
-3.84%
End price
05.11.21
€72.60
Summary
This prediction ended on 05.11.21 with a price of €72.60. With a performance of -3.84%, the BUY prediction by skatcup finished with a loss. A total of €2.83 was paid as dividends for this prediction. skatcup has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Novartis AG ADR | 5.505% | 5.505% | 0.877% | 26.027% |
| iShares Core DAX® | 1.804% | -0.748% | 13.168% | 16.408% |
| iShares Nasdaq 100 | -0.182% | -3.412% | 39.976% | 43.502% |
| iShares Nikkei 225® | 0.413% | -7.381% | 18.776% | 2.874% |
| iShares S&P 500 | 0.664% | -1.941% | 28.141% | 42.155% |
According to skatcup what are the pros and cons of Novartis AG ADR for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
High dividend yield expected
positive Cash Flow expected
Good rating
ROE higher than 10% per year
Normal challenges to pay loans and raise capital
Capable Management
Differentiated customer and product portfolio
Stable Large shareholder and/or long term investor
Medium risks for its business
Top 10 in its market
Small cyclical dependencies
Known brand
Future proof or reliable business model
Cons
Comments by skatcup for this prediction
In the thread Novartis AG ADR diskutieren
Buy Novartis AG ADR
Kursziel gesetzt auf 90,0
In the thread Trading Novartis AG ADR
Die von skatcup gewählte maximale Laufzeit wurde überschritten